Skip to content

Preloaded Combination Nicotine Replacement Therapy on Smoking Cessation of Adult Population in Kazakhstan

Effectiveness of Preloaded Combination Nicotine Replacement Therapy on Smoking Cessation of Adult Population in Kazakhstan- A Randomized Controlled Trial

Status
UNKNOWN
Phases
Early Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05484505
Enrollment
200
Registered
2022-08-02
Start date
2023-07-01
Completion date
2024-12-31
Last updated
2023-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Smoking Behaviors, Smoking Cessation, Smoking, Cigarette

Keywords

Tobacco, Smoking, Nicotine Patches, Nicotine Gums, Nicotine Replacement Therapy, Preloading

Brief summary

Randomized, controlled, two-armed, single-blinded, superiority trial with 1:1 allocation ratio Nicotine Replacement Therapy(NRT)

Detailed description

The primary objective is to determine the effectiveness of preloaded combination nicotine replacement therapy (NRT) on smoking cessation of tobacco smokers. The secondary objectives are to determine the predictors of smoking cessation among the study participant's, to determine the change in health-related quality of life due to smoking cessation & to determine the perception of treatment adherence among the study participants.

Interventions

DRUGNicotine patch, Nicotine gums

Nicotine patch 21mg, 12 weeks post quit date and nicotine chewing gums 4mg for 12 weeks post quit date * 14 mg: Next 4 weeks * 7 mg: Last 4 weeks

BEHAVIORALBrief Advice (5 A's & 5 R's)

Brief Advice (5 A's & 5 R's) at Day 0, 1 month, 3,6,9 & 12 months

DRUGNicotine Patch: Preloading for 4 weeks

Nicotine Patch: Preloading for 4 weeks - 21 mg: 4 weeks before quit date

Sponsors

Astana Medical University
CollaboratorOTHER
Nazarbayev University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* all current smokers aged 18 years and above with a motivation to quit

Exclusion criteria

* smokeless tobacco users, smoking frequency of fewer than 10 cigarettes per day, pregnant women, lactating women, patients with a recent history of myocardial infarction of fewer than 3 months, and electronic cigarette users

Design outcomes

Primary

MeasureTime frameDescription
Self reported smoking during intervention period : Yes/NoAssessed at 12 months from the starting point of intervention.Self-reported smoking anytime during the intervention or follow-up period
Salivary cotinine test results: Positive or NegativeSalivary cotinine test results before intervention, after the intervention and after follow upsSalivary cotinine test results before, during and after the intervention

Secondary

MeasureTime frameDescription
Self reported number of quit attempts of tobaccoAssessed at 3, 6 & 12 months from the starting point of intervention.Number of quit attempts of tobacco since enrolment
Self reported number of smoked cigarettes/bidis per dayAssessed at 12 months from the starting point of intervention.Number of smoked cigarettes/bidis per day since enrolment
Adherence to intervention in days: Self reportedAssessed at 12 months from the starting point of intervention.Self reported duration of use of the intervention in days

Other

MeasureTime frameDescription
Pattern of smokingAssessed at 12 months from the starting point of intervention.The change in smoking frequency from the baseline information (It can be excess use, reduced use or relapse)

Countries

Kazakhstan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 7, 2026